Want to see SABS full AI Analyst Report?
Compare SAB Biotherapeutics (SABS) vs. Competitors
Comparison Results
| Name | Price | Market Cap | P/E Ratio | Yearly Gain | Analyst Consensus | Analyst Price Target | Compare | Top Analysts' Price Target | Smart Score | Follow |
|---|---|---|---|---|---|---|---|---|---|---|
| SABSSAB Biotherapeutics | $3.31 | $304.80M | 0.92 | 1.54% | Strong Buy | Unlock the SABS analyst price target with TipRanks Premium | SABS | Unlock the SABS top-analyst price target with TipRanks Premium | ||
| LSTALisata Therapeutics | $1.04 | $11.02M | -0.61 | -63.80% | ― | Unlock the LSTA analyst price target with TipRanks Premium | SABS vs LSTA | Unlock the LSTA top-analyst price target with TipRanks Premium | ||
| NXTCNextCure | $5.64 | $28.88M | -0.54 | -54.80% | Moderate Buy | Unlock the NXTC analyst price target with TipRanks Premium | SABS vs NXTC | Unlock the NXTC top-analyst price target with TipRanks Premium | ||
| RLYBRallybio | $15.70 | $83.67M | 3.42 | 182.49% | ― | Unlock the RLYB analyst price target with TipRanks Premium | SABS vs RLYB | Unlock the RLYB top-analyst price target with TipRanks Premium |
Performance Comparison
| Ticker | Company Name | Price | Change | % Change | |
|---|---|---|---|---|---|
| SABS | SAB Biotherapeutics | 3.30 | 0.05 | 1.54% | |
| LSTA | Lisata Therapeutics | 1.01 | -1.66 | -62.17% | |
| NXTC | NextCure | 5.70 | -6.29 | -52.46% | |
| RLYB | Rallybio | 15.76 | 10.42 | 194.91% |
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts
